Michael Smith's most recent trade in Insmed Inc was a trade of 1,396 Common Stock done at an average price of $173.3 . Disclosure was reported to the exchange on Jan. 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 173.33 per share. | 06 Jan 2026 | 1,396 | 58,799 (0%) | 0% | 173.3 | 241,969 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 174.17 per share. | 06 Jan 2026 | 1,053 | 57,037 (0%) | 0% | 174.2 | 183,401 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 175.07 per share. | 06 Jan 2026 | 709 | 58,090 (0%) | 0% | 175.1 | 124,125 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 27,600 | 27,600 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 5,293 | 60,195 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.75 per share. | 03 Nov 2025 | 27,130 | 82,032 (0%) | 0% | 23.8 | 644,338 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 27,130 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 181.88 per share. | 03 Nov 2025 | 7,619 | 73,071 (0%) | 0% | 181.9 | 1,385,744 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 182.60 per share. | 03 Nov 2025 | 4,286 | 68,785 (0%) | 0% | 182.6 | 782,624 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 183.92 per share. | 03 Nov 2025 | 4,032 | 64,753 (0%) | 0% | 183.9 | 741,565 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 185.93 per share. | 03 Nov 2025 | 3,636 | 57,874 (0%) | 0% | 185.9 | 676,041 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 184.91 per share. | 03 Nov 2025 | 3,243 | 61,510 (0%) | 0% | 184.9 | 599,663 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 187.15 per share. | 03 Nov 2025 | 1,572 | 56,302 (0%) | 0% | 187.2 | 294,200 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 187.97 per share. | 03 Nov 2025 | 1,400 | 54,902 (0%) | 0% | 188.0 | 263,158 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 181.01 per share. | 03 Nov 2025 | 1,342 | 80,690 (0%) | 0% | 181.0 | 242,915 | Common Stock |
| Tillys Inc (Class A) | Nathan Michael Smith | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2025 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Tillys Inc (Class A) | Nathan Michael Smith | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2025 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Ulta Beauty | Michael C. Smith | Director | Sale of securities on an exchange or to another person at price $ 528.43 per share. | 04 Sep 2025 | 500 | 2,263 (0%) | 0% | 528.4 | 264,215 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 12,780 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.46 per share. | 02 Sep 2025 | 12,780 | 79,174 (0%) | 0% | 30.5 | 389,279 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.16 per share. | 02 Sep 2025 | 8,300 | 61,029 (0%) | 0% | 144.2 | 1,196,528 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 143.16 per share. | 02 Sep 2025 | 7,391 | 69,329 (0%) | 0% | 143.2 | 1,058,096 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 145.18 per share. | 02 Sep 2025 | 4,944 | 56,085 (0%) | 0% | 145.2 | 717,770 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 141.16 per share. | 02 Sep 2025 | 1,354 | 77,820 (0%) | 0% | 141.2 | 191,131 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 145.89 per share. | 02 Sep 2025 | 1,183 | 54,902 (0%) | 0% | 145.9 | 172,588 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 142.06 per share. | 02 Sep 2025 | 1,100 | 76,720 (0%) | 0% | 142.1 | 156,266 | Common Stock |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.16 per share. | 05 Aug 2025 | 2,211 | 109,389 (0%) | 0% | 53.2 | 117,537 | Common Stock |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.46 per share. | 29 Jul 2025 | 718 | 111,601 (0%) | 0% | 59.5 | 42,692 | Common Stock |
| Teledyne Tech | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 560.10 per share. | 28 Jul 2025 | 1,975 | 51,328 (0%) | 0% | 560.1 | 1,106,198 | Common Stock |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 72,447 | 72,447 | - | - | Employee Stock Option (Right to Buy) | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 34,505 | 112,319 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 10,687 | 82,289 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.79 per share. | 15 Jul 2025 | 4,475 | 77,814 (0%) | 0% | 49.8 | 222,810 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 102.51 per share. | 11 Jul 2025 | 933 | 66,394 (0%) | 0% | 102.5 | 95,642 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 96.41 per share. | 11 Jul 2025 | 748 | 67,327 (0%) | 0% | 96.4 | 72,115 | Common Stock |
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 1,248 | 1,790 | - | - | Phantom Stock | |
| Ulta Beauty | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 383 | 2,763 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.50 per share. | 05 Jun 2025 | 1,879 | 67,718 (0%) | 0% | 73.5 | 138,107 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 03 Jun 2025 | 1,448 | 69,597 (0%) | 0% | 71.5 | 103,532 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 30 May 2025 | 20,000 | 71,045 (0%) | 0% | 70 | 1,400,000 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 68.56 per share. | 30 May 2025 | 6,327 | 91,045 (0%) | 0% | 68.6 | 433,779 | Common Stock |
| Massimo Grp | Michael Smith | Former Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 50,000 | - | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 27,100 | 27,100 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,578 | 97,372 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 67.81 per share. | 13 May 2025 | 4,407 | 92,203 (0%) | 0% | 67.8 | 298,839 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 65.61 per share. | 13 May 2025 | 409 | 91,794 (0%) | 0% | 65.6 | 26,834 | Common Stock |
| Zebra Tech (Class A) | Michael A. Smith | Director | Grant, award, or other acquisition of securities at price $ 265.37 per share. | 08 May 2025 | 830 | 10,695 (0%) | 0% | 265.4 | 220,257 | Class A Common Stock |
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 2,890 | 2,890 | - | - | Stock Option (right to buy) | |
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 860 | 860 (0%) | 0% | 0 | Common Stock | |
| Teledyne Tech | Michael T. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 468 | 53,303 (0%) | 0% | 0 | Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 4,848 | 4,848 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,744 | 17,875 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,744 | 3,488 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,375 | 19,451 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,375 | 1,375 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,039 | 18,389 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 1,039 | 0 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.73 per share. | 07 Mar 2025 | 525 | 17,350 (0%) | 0% | 46.7 | 24,533 | V2X, Inc. Common Stock |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.65 per share. | 07 Mar 2025 | 414 | 19,037 (0%) | 0% | 46.6 | 19,313 | V2X, Inc. Common Stock |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.65 per share. | 07 Mar 2025 | 313 | 18,076 (0%) | 0% | 46.6 | 14,601 | V2X, Inc. Common Stock |
| McCormick & Company | Michael R. Smith | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.96 per share. | 18 Feb 2025 | 9,964 | 120,498 (1%) | 0% | 77.0 | 766,829 | Common Stock - Voting |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 47,295 | 117,260 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 80.90 per share. | 05 Feb 2025 | 20,650 | 96,610 (0%) | 0% | 80.9 | 1,670,585 | Common Stock |
| McCormick & Company | Michael R. Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,764 | 130,462 (1%) | 0% | 0 | Common Stock - Voting | |
| Teledyne Tech | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 510.50 per share. | 27 Jan 2025 | 2,100 | 52,835 (0%) | 0% | 510.5 | 1,072,050 | Common Stock |
| MillerKnoll Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 9,905 | 9,905 | - | - | Non-Qualified Stock Option (right to buy) | |
| MillerKnoll Inc | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 21.90 per share. | 15 Jan 2025 | 5,936 | 30,810 (0%) | 0% | 21.9 | 129,998 | Common Stock |
| MillerKnoll Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 3,835 | 19,756 | - | - | Phantom Stock | |
| MillerKnoll Inc | Michael R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 508 | 19,247 | - | - | Phantom Stock | |
| MillerKnoll Inc | Michael R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.91 per share. | 15 Jan 2025 | 508 | 1,793 (0%) | 0% | 21.9 | 11,132 | Common Stock |
| McCormick & Company | Smith Michael R. | Executive Vice President | 20 Dec 2024 | 2,325 | 232 (0%) | 0% | - | Common Stock - Non Voting | ||
| Teledyne Tech | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 478.25 per share. | 12 Dec 2024 | 2,025 | 54,935 (0%) | 0% | 478.2 | 968,456 | Common Stock |
| McCormick & Company | Smith R. Michael | Executive Vice President | 02 Dec 2024 | 1,479 | 1,479 | - | - | Restricted Stock Units | ||
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 539 | 539 | - | - | Phantom Stock | |
| Massimo Grp | Michael Smith | Vice President | 22 Nov 2024 | 25,000 | 25,000 | - | 0 | Common Stock | ||
| McCormick & Company | Michael R. Smith | Executive VP & CFO | 15 Nov 2024 | 2,350 | 109,698 (1%) | 0% | - | Common Stock - Voting | ||
| McCormick & Company | Michael R. Smith | Executive VP & CFO | 15 Nov 2024 | 2,350 | 2,557 (0%) | 0% | - | Common Stock - Non Voting | ||
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 74.16 per share. | 13 Sep 2024 | 18,871 | 76,856 (0%) | 0% | 74.2 | 1,399,473 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 74.75 per share. | 13 Sep 2024 | 9,000 | 67,856 (0%) | 0% | 74.8 | 672,750 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.76 per share. | 13 Sep 2024 | 7,000 | 95,727 (0%) | 0% | 22.8 | 159,320 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2024 | 7,000 | 0 | - | - | Stock Option (right to buy) | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Purchase of securities on an exchange or from another person at price $ 48.00 per share. | 06 Sep 2024 | 416 | 16,131 (0%) | 0% | 48 | 19,968 | V2X, Inc. Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 72.75 per share. | 12 Aug 2024 | 67,655 | 109,142 (0%) | 0% | 72.7 | 4,921,901 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 41,640 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.91 per share. | 12 Aug 2024 | 41,640 | 142,267 (0%) | 0% | 13.9 | 579,212 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 34,530 | 34,530 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 12 Aug 2024 | 34,530 | 176,797 (0%) | 0% | 17.1 | 589,427 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.65 per share. | 12 Aug 2024 | 20,415 | 88,727 (0%) | 0% | 73.7 | 1,503,565 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 11,900 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share. | 12 Aug 2024 | 11,900 | 100,627 (0%) | 0% | 17.2 | 204,204 | Common Stock |
| Lamb Weston | Michael Jared Smith | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.38 per share. | 06 Aug 2024 | 1,107 | 71,084 (0%) | 0% | 57.4 | 63,520 | Common Stock |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2024 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2024 | 50,000 | 120,331 (0%) | 0% | - | Class A Common Stock | |
| PetIQ Inc Ordinary Shares | Michael A Smith | PRESIDENT & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.44 per share. | 05 Aug 2024 | 22,523 | 97,808 (0%) | 0% | 21.4 | 482,893 | Class A Common Stock |
| Lamb Weston | Michael Jared Smith | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.23 per share. | 29 Jul 2024 | 10,415 | 72,191 (0%) | 0% | 56.2 | 585,635 | Common Stock |
| Lamb Weston | Michael Jared Smith | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 13,225 | 82,608 (0%) | 0% | 0 | Common Stock | |
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 760 | 780 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.05 per share. | 08 Jul 2024 | 730 | 88,727 (0%) | 0% | 70.1 | 51,137 | Common Stock |
| Ulta Beauty | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 452 | 2,380 (0%) | 0% | 0 | Common Stock | |
| Tutor Perini Corp | Michael Francis Smithson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 50,000 | 72,825 (0%) | 0% | - | Common Stock | |
| Tutor Perini Corp | Michael Francis Smithson | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 50,000 | 0 | - | - | Restricted Stock Units |